Combined dyslipidemia in childhood

Area of Science:

• Pediatric Endocrinology
• Cardiovascular Health
• Metabolic Disorders

Background:

• Combined dyslipidemia (CD) is the primary lipid disorder in children, characterized by elevated triglycerides and non-HDL cholesterol, with low HDL cholesterol.
• This pattern is strongly associated with childhood obesity, affecting over 40% of obese adolescents.
• CD in youth is a predictor of atherosclerosis, vascular dysfunction, and early cardiovascular events in adulthood.

Purpose of the Study:

• To review the characteristics and implications of combined dyslipidemia in childhood.
• To highlight the connection between CD, obesity, insulin resistance, and metabolic syndrome.
• To summarize evidence-based strategies for managing childhood CD through lifestyle interventions and discuss drug therapy.

Main Methods:

• Literature review of studies on childhood combined dyslipidemia.
• Analysis of lipid subpopulations using nuclear magnetic resonance spectroscopy.
• Evaluation of the impact of weight loss, diet modification, and physical activity on CD.
• Review of evidence for pharmacologic treatment in pediatric CD.

Main Results:

• CD is characterized by increased small, dense LDL and LDL particle number, with reduced HDL-C and large HDL particles, indicating an atherogenic profile.
• Weight loss, dietary changes (especially reducing simple carbohydrates and sugar-sweetened beverages), and increased physical activity significantly improve CD in children.
• Even modest weight loss leads to substantial improvements in triglyceride and HDL-C levels and lipid subpopulations.

Conclusions:

• Combined dyslipidemia in childhood is a significant health concern linked to obesity and metabolic syndrome, predicting long-term cardiovascular risk.
• Lifestyle modifications, including diet and exercise, are highly effective in managing pediatric CD.
• While lifestyle changes are primary, drug therapy may be considered in select cases.